Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
CURRENT ASSETS:    
Cash and cash equivalents $ 4,825 $ 4,278
Short-term deposits 3,057 4,625
Prepaid expenses, and other current assets 1,095 986
Short-term investment 5 19
Total current assets 8,982 9,908
NON-CURRENT ASSETS:    
Operating lease right of use assets 111 52
Property, plant and equipment, net 27 29
Total non-current assets 138 81
Total assets 9,120 9,989
CURRENT LIABILITIES:    
Trade payables 618 427
Current maturity of operating lease liability 53 27
Deferred revenues 405 622
Other accounts payable 976 944
Total current liabilities 2,052 2,020
NON-CURRENT LIABILITIES:    
Long-term operating lease liability 51 13
Deferred revenues 1,581 1,713
Total non-current liabilities 1,632 1,726
CONTINGENT LIABILITIES AND COMMITMENTS  
SHAREHOLDERS’ EQUITY:    
Ordinary shares of no par value - Authorized: 10,000,000,000 and 5,000,000,000 shares at December 31, 2024 and 2023, respectively; Issued and outstanding: 2,983,181,793 and 1,359,837,393 shares as of December 31, 2024 and 2023, respectively.
Additional paid-in capital 170,670 163,597
Accumulated other comprehensive income 1,127 1,127
Accumulated deficit (166,361) (158,481)
Total shareholders’ equity 5,436 6,243
Total liabilities and shareholders’ equity $ 9,120 $ 9,989